Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BISOLVON ® - Healthy
    Clinical Study Number 65.129
    Study Indication Healthy
    Product BISOLVON ®
    Generic Name Bromhexine
    Lab Code
    Clinical Phase I
    Study Title

    Relative bioavailability of bromhexine for oral administration of 16 mg of bromhexine hydrochloride granules compared to 16 mg of bromhexine hydrochloride syrup in healthy male and female volunteers (an open-label, randomised, single-dose, replicate design Phase I study with two treatments in four crossover periods)

    Study Document
    Trial synopsis 65.129_DR english